Anavex Life Sciences Corp (AVXL)

[raja48185]

With FULL Rett data(both Avatar and Excellence)read out possible only in 2022, do you think that AVXL can hit $40, let alone $50? Even so, does it have the 'staying power'? PDD peer review can happen anytime in 2021(hopefully) and 3-71 data read out should be coming by EOY; but can these sustain the pps for more than a couple of days before it sags?

Will FDA throw us a BTD-bone for PDD that may turn the tide for good?

Those who think that AD data read out will happen in early June 2022, following completion of the trial should take a moment and give it a thought. I would add anywhere between 3 to 6 months for the complete data read out (3 months for top line and 6 for the complete data)even though the pps may react very positively as the date with destiny gets closer - going by recent examples of SAVA and ANVS - or would Wall Street still act indifferent when it comes to AVXL?)

Lot of questions; time will tell; Until then we do what is best - Wait and Watch.